D. Gladman

3.5k total citations · 1 hit paper
37 papers, 2.7k citations indexed

About

D. Gladman is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, D. Gladman has authored 37 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Rheumatology, 15 papers in Immunology and 7 papers in Hematology. Recurrent topics in D. Gladman's work include Rheumatoid Arthritis Research and Therapies (20 papers), Systemic Lupus Erythematosus Research (17 papers) and Spondyloarthritis Studies and Treatments (15 papers). D. Gladman is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (20 papers), Systemic Lupus Erythematosus Research (17 papers) and Spondyloarthritis Studies and Treatments (15 papers). D. Gladman collaborates with scholars based in Canada, United States and United Kingdom. D. Gladman's co-authors include Richard J. Cook, Vernon T. Farewell, Janice Husted, Murray B. Urowitz, Mahmoud Abu‐Shakra, Ian N Bruce, Michael Easterbrook, Frances Stafford-Brady, Philip J. Mease and Anju Kagal and has published in prestigious journals such as Journal of Clinical Epidemiology, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

D. Gladman

35 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Methods for assessing responsiveness

2000 1.2k citations Janice Husted, Richard J. Cook et al. Journal of Clinical Epidemiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Gladman Canada	19	1.4k	714	428	337	278	37	2.7k
D. van der Heijde Netherlands	22	2.7k 1.9×	555 0.8×	576 1.3×	828 2.5×	284 1.0×	36	3.2k
A J Silman United Kingdom	32	1.4k 1.0×	462 0.6×	530 1.2×	421 1.2×	422 1.5×	100	3.7k
Ann Bremander Sweden	24	1.1k 0.8×	356 0.5×	653 1.5×	425 1.3×	111 0.4×	130	2.4k
Hanne Dagfinrud Norway	34	2.1k 1.5×	607 0.9×	493 1.2×	982 2.9×	210 0.8×	125	3.5k
Björn Svensson Sweden	33	2.5k 1.8×	333 0.5×	575 1.3×	584 1.7×	354 1.3×	116	3.9k
J F Fries United States	18	1.3k 0.9×	180 0.3×	365 0.9×	509 1.5×	293 1.1×	25	2.7k
J. M. W. Hazes Netherlands	27	2.1k 1.5×	366 0.5×	661 1.5×	599 1.8×	265 1.0×	61	3.1k
N. Hajjaj‐Hassouni Morocco	32	1.6k 1.1×	457 0.6×	829 1.9×	602 1.8×	689 2.5×	218	3.6k
Matthias Englbrecht Germany	36	2.1k 1.5×	783 1.1×	517 1.2×	657 1.9×	179 0.6×	107	3.2k
Klaus Machold Austria	39	3.6k 2.5×	860 1.2×	418 1.0×	1.4k 4.1×	664 2.4×	104	5.2k

Countries citing papers authored by D. Gladman

Since Specialization

Citations

This map shows the geographic impact of D. Gladman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Gladman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Gladman more than expected).

Fields of papers citing papers by D. Gladman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Gladman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Gladman. The network helps show where D. Gladman may publish in the future.

Co-authorship network of co-authors of D. Gladman

This figure shows the co-authorship network connecting the top 25 collaborators of D. Gladman. A scholar is included among the top collaborators of D. Gladman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Gladman. D. Gladman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kharouf, Fadi, et al.. (2025). Does the time to the onset of lupus nephritis impact renal disease presentation and outcomes?. Seminars in Arthritis and Rheumatism. 73. 152724–152724.

Kharouf, Fadi, et al.. (2024). Short- and long-term outcomes of patients with pure membranous lupus nephritis compared with patients with proliferative disease. Lara D. Veeken. 64(4). 1912–1922. 4 indexed citations

Helliwell, P, Éric Lespessailles, Catherine L Shuler, et al.. (2018). Ixekizumab Provides Sustained Improvement In Signs And Symptoms In Patients With Active Psoriatic Arthritis: Two Year Results From A Phase 3 Trial. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 1 indexed citations

Wollenhaupt, J., D. Gladman, C. Stach, et al.. (2013). Effect Of Certolizumab Pegol Over 48 Weeks On Signs and Symptoms In Patients With Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Exposure. The Journal of Rheumatology. 41(7). 1448–1449. 3 indexed citations

Touma, Zahi, et al.. (2012). Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months. Lara D. Veeken. 51(10). 1814–1819. 36 indexed citations

Kavanaugh, Arthur, D. van der Heijde, Iain B. McInnes, et al.. (2012). 5 Year Safety, Efficacy, and Radiographic Data in Patients with Active Psoriatic Arthritis Treated with Golimumab: Results From the Long-Term Extension of a Randomized, Placebo-Controlled Study. Data Archiving and Networked Services (DANS). 64(10). 1 indexed citations

Gladman, D.. (2012). Future Trends in Research in Psoriatic Arthritis. PubMed. 89(0). 106–110. 3 indexed citations

Kavanaugh, Arthur, D. van der Heijde, D. Gladman, et al.. (2010). GOLIMUMAB INHIBITS PROGRESSION OF RADIOGRAPHIC DAMAGE IN PATIENTS WITH PSORIATIC ARTHRITIS: 52 WEEK RESULTS FROM THE GO-REVEAL STUDY. Lara D. Veeken. 50. 143–143. 9 indexed citations

Eder, Lihi, V. Chandran, Catherine T. Schentag, et al.. (2010). Time and predictors of response to tumour necrosis factor- blockers in psoriatic arthritis: an analysis of a longitudinal observational cohort. Lara D. Veeken. 49(7). 1361–1366. 28 indexed citations

10.

Choy, Ernest, D. Gladman, Christopher T. Ritchlin, et al.. (2009). IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING ADALIMUMAB, IMPROVEMENT IN PSORIASIS IS ASSOCIATED WITH LONG-TERM INHIBITION OF RADIOGRAPHIC PROGRESSION. Lara D. Veeken. 48. 1 indexed citations

11.

Ory, P A, D. Gladman, & Philip J. Mease. (2005). Psoriatic arthritis and imaging. Annals of the Rheumatic Diseases. 64. ii55–ii57. 97 indexed citations

12.

Gladman, D., et al.. (2001). Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.. PubMed. 28(4). 761–5. 87 indexed citations

13.

Gladman, D., et al.. (2001). HLA-DRB1∗04 alleles in psoriatic arthritis: comparison with rheumatoid arthritis and healthy controls. Human Immunology. 62(11). 1239–1244. 17 indexed citations

14.

Bruce, Ian N, et al.. (2000). Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities.. PubMed. 27(10). 2372–7. 71 indexed citations

15.

Husted, Janice, Richard J. Cook, Vernon T. Farewell, & D. Gladman. (2000). Methods for assessing responsiveness. Journal of Clinical Epidemiology. 53(5). 459–468. 1190 indexed citations breakdown →

16.

Gladman, D., C. H. Goldsmith, Murray B. Urowitz, et al.. (1992). Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus.. PubMed. 19(4). 608–11. 103 indexed citations

17.

Khraishi, Majed, D. Gladman, Pierre Dagenais, Adel G. Fam, & Edward Keystone. (1992). HLA antigens in north american patients with takayasu arteritis. Arthritis & Rheumatism. 35(5). 573–575. 32 indexed citations

18.

Gladman, D.. (1990). Prognosis of systemic lupus erythematosus and factors that affect it. Current Opinion in Rheumatology. 2(5). 694–702. 16 indexed citations

19.

Stafford-Brady, Frances, et al.. (1988). Lupus retinopathy. Arthritis & Rheumatism. 31(9). 1105–1110. 135 indexed citations

20.

Hanley, John, et al.. (1988). PSORIATIC SPONDYLARTHROPATHY: A LONG TERM PROSPECTIVE STUDY. 47(5). 386–393. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact